fter a bruising 2023, there are some signs that funding for digital health startups in Europe is on the mend in 2024.
The sector picked up just $1.2bn last year, according to Dealroom — the lowest figure since 2018 and a long drop from the $3.1bn raised during the heady days of 2021. That sum has already been reached so far in 2024 — courtesy of the return of a couple of nine-figure funding rounds — and there’s still two months left to play with.
The three biggest digital health equity raises of 2024 — period tracking appFlo’s $200m, insurtechAlan’s $173mand surgery platformCaresyntax’s $80m— all topped 2023’s largest, digi-physical health platformPatient21’s €70m Series C.
There are, however, still big challenges commercialising. Founders tell Sifted it remains difficult selling into fragmented public health systems across Europe, and no startup has yet managed to hit real scale with a direct-to-consumer healthcare product in the region.
Despite that, startups doing both of those things have seen real growth